apl. Prof. Dr. Simone Bertz

Medizinische Fakultät Institute of Pathology

Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy (2016) Bertz S, Wach S, Taubert H, Merten R, Krause FS, Schick S, Ott OJ, et al. Journal article Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract (2016) Agaimy A, Bertz S, Cheng L, Hes O, Junker K, Keck B, Lopez-Beltran A, et al. Journal article Anamnese, pathologische Originalbefunde, Therapie bezogene Parameter und Krankheitsverlauf: retrospektive Analyse von klinisch basierten Faktoren für die Prognose des tumorspezifischen Überlebens von 378 Patienten mit pT1-Harnblasenkarzinom (2015) Breyer J, Otto W, Hartmann A, Bumes B, Bruendl J, Gierth M, Bertz S, et al. Journal article, Original article Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients (2015) Taubert H, Wach S, Jung R, Pugia M, Keck B, Bertz S, Nolte E, et al. Journal article Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients (2015) Keck B, Wach S, Taubert H, Zeiler S, Ott OJ, Kunath F, Hartmann A, et al. Journal article Mesothelial/monocytic incidental cardiac excrescences (cardiac MICE) associated with acute aortic dissection: a study of two cases (2015) Strecker T, Bertz S, Wachter DL, Weyand M, Agaimy A Journal article Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer (2014) Bertz S, Abee C, Schwarz-Furlan S, Alfer J, Hofstaedter F, Stoehr R, Hartmann A, Gaumann AKA Journal article Prognostic and predictive molecular markers for urologic cancers (2014) Hartmann A, Schlomm T, Bertz S, Heinzelmann J, Hoelters S, Simon R, Stoehr R, Junker K Journal article Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11 (2014) Drayton RM, Dudziec E, Peter S, Bertz S, Hartmann A, Bryant HE, Catto JWF Journal article Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours (2014) Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, et al. Journal article